Printer Friendly

COMPANY INFORMATION
Angiotech Pharmaceuticals, Inc. 1618 Station St Vancouver, BC V6A 1B6 Tel: (604) 221-7676 Fax: (604) 221-2330 Contact Name DeDe Sheel Industry Biotechnology		Key Executives William L. Hunter, CEO K. Thomas Bailey, CFO Develops and commercializes medical device coatings and treatments for chronic inflammatory diseases through the combination of pharmaceutical compounds with medical devices and biomaterials. Lead products include paclitaxel-eluting coronary stent systems, paclitaxel-eluting mesh, paclitaxel-eluting peripheral vascular stent and self-retaining polydioxanone systems.
FP ADVISOR COVERAGE Angiotech Pharmaceuticals, Inc. • FP Corporate Analyzer • FP Directory of Directors • FP Corporate Surveys • FP Investor Reports • Ordering FP Products		TOP INDUSTRY PLAYERS Biotechnology Company Name Revenue ($000s)  Atrium Innovations Inc. 309,546 Angiotech Pharmaceuticals, Inc. 302,251 QLT Inc. 132,457 Oncothyreon Inc. 42,678 AEterna Zentaris Inc. 41,056 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 5/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX/ANP Nasdaq/ANPI $1.13 $3.10 $0.35 n.a. n.a. n.a. 3.74 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 69,573 n.a. US$-0.99 Sept. 30/09 88.33% -49.3% -45.04% $96,206
ANNUAL FINANCIALS Periods ended: 12m Dec. 31/08A 12m Dec. 31/07A 12m Dec. 31/06A US$000s US$000s US$000s Operating revenue 283,272 287,694 315,075 Net income (741,176) (65,940) 4,585 Total assets 385,197 1,150,108 1,205,874 US$ US$ US$ Earnings per share* (8.71) (0.78) 0.05 % % % Return on equity n.m. (12.12) 2.60   * Common A Reported in accordance with U.S. GAAP
TRAILING 12-MONTH VALUES Periods ended: Sept. 30/09A Sept. 30/08A US$000s US$000s Operating revenue 278,199 292,550 Net income (84,199) (692,068) US$ US$ Earnings per share (0.99) (8.14)   A Reported in accordance with U.S. GAAP

COMPANY NEWS

Results for 'Angiotech Pharmaceuticals, Inc.' from past 30 days: No hits. (Links are to articles.)